Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-009546
Filing Date
2005-09-13
Accepted
2005-09-13 16:58:26
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 VIRAGEN, INC. g97328e10vk.htm 10-K 962285
2 SUBSIDIARIES OF REGISTRANT g97328exv21w1.htm EX-21.1 5728
3 CONSENT OF ERNST & YOUNG LLP g97328exv23w1.htm EX-23.1 3372
4 SECTION 302 CEO CERTIFICATION g97328exv31w1.htm EX-31.1 5092
5 SECTION 302 CFO CERTIFICATION g97328exv31w2.htm EX-31.2 5095
6 SECTION 906 CEO CERTIFICATION g97328exv32w1.htm EX-32.1 3344
7 SECTION 906 CFO CERTIFICATION g97328exv32w2.htm EX-32.2 3352
8 GRAPHIC g97328g9732801.gif GRAPHIC 6494
  Complete submission text file 0000950144-05-009546.txt   998808
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746
VIRAGEN INC (Filer) CIK: 0000353482 (see all company filings)

EIN.: 592101668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15823 | Film No.: 051082717
SIC: 2836 Biological Products, (No Diagnostic Substances)